Skip to main content

Correction: Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model

The Original Article was published on 11 January 2019

Correction : Stem Cell Research & Therapy (2019) 10:17 https://doi.org/10.1186/s13287-018-1111-y

Following publication of this article [1], the authors found that incorrect representative echocardiographic images were mistakenly included in Fig. 5a (MSCs-mCherry group and MSCs-Fstl1 group) during manuscript preparation, which partially overlapped with representative echocardiographic images in our other contemporaneous article (Fig. 4A, MI/antagomir NC group, MI/miR-9-5p antagomir group) [2]. In response, the authors updated all representative images in Fig. 5a and re-evaluated all raw images, generating accompanying Fig. 5b–g with dot-plots indicated. All raw echocardiographic images related to Fig. 5a–g were provided as supplementary (Additional file 1: Figure S1). Notably, the main conclusions of this article remain consistent throughout.

References

  1. Shen H, Cui G, Li Y, et al. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem Cell Res Ther. 2019;10:17. https://doi.org/10.1186/s13287-018-1111-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Xiao Y, et al. Inhibition of microRNA-9 protects against cardiac remodeling following myocardial infarction in mice. Hum Gene Ther. 2019;30:286–301. https://doi.org/10.1089/hum.2018.059.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Weiqian Chen or Zhenya Shen.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

. Figure S1. All raw echocardiographic images related to Figure 5a-g.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, H., Cui, G., Li, Y. et al. Correction: Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem Cell Res Ther 15, 47 (2024). https://doi.org/10.1186/s13287-024-03662-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-024-03662-y